Lovastatin / niacin Pregnancy and Breastfeeding Warnings

Brand names: Advicor

Lovastatin / niacin Pregnancy Warnings

Lovastatin-niacin has been assigned to pregnancy category X by the FDA. Animal studies for the combination product have not been reported, however lovastatin has been shown to produce skeletal malformations at plasma levels 40 times the human exposure (mice) and 80 times the human exposure (rats). There are no controlled data in human pregnancy. Lovastatin-niacin use is considered contraindicated during pregnancy.

See references

Lovastatin / niacin Breastfeeding Warnings

There are no data on the excretion of lovastatin into human milk. Niacin is excreted in human milk. The effects in the nursing infant are unknown, however, the potential for serious adverse reactions in nursing infants from lipid-altering doses of lovastatin and niacin warrants that the drug(s) not be administered to nursing mothers. Lovastatin-niacin is considered contraindicated during breast-feeding by the American Academy of Pediatrics.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer